Bioluminescence imaging to monitor treatment response.

<p>A) Representative images of bioluminescence 3–5 weeks after tumour cell injection showing tumour progression in a B20–4.1 mouse and a control mouse. B) Quantification of total flux relative to baseline (week 0). Values are expressed as mean ± SEM after one week of treatment in the control (n = 13), the B20 group (n = 11) and the B20+TB403 group (n = 8); and after two weeks of treatment in the control (n = 9), the B20 (n = 9) and the B20+TB403 group (n = 6). *<i>p</i><0.05